about
Mutation of POLB causes lupus in miceSalivary Gland Dysplasia in Fgf10 Heterozygous Mice: A New Mouse Model of Xerostomia.Anti-inflammatory effects of rebamipide eyedrop administration on ocular lesions in a murine model of primary Sjögren's syndrome.Inhibition of lysophosphatidic acid receptor ameliorates Sjögren's syndrome in NOD mice.The osteopontin transgenic mouse is a new model for Sjögren's syndromeReduction of T cell receptor diversity in NOD mice prevents development of type 1 diabetes but not Sjögren's syndrome.Single-cell analysis reveals isotype-specific autoreactive B cell repertoires in Sjögren's syndrome.Establishment of the mild, moderate and severe dry eye models using three methods in rabbitsInvestigation of novel autoantibodies in Sjogren's syndrome utilizing Sera from the Sjogren's international collaborative clinical alliance cohort.Mouse Models of Primary Sjogren's Syndrome.Transduction, tropism, and biodistribution of AAV vectors in the lacrimal glandLymphotoxin-beta receptor blockade reduces CXCL13 in lacrimal glands and improves corneal integrity in the NOD model of Sjögren's syndromeSecretory glands and microvascular systems imaged in aqueous solution by atmospheric scanning electron microscopy (ASEM).Sexual dimorphism in an animal model of Sjögren's syndrome: a potential role for Th17 cells.Primary biliary cirrhosis and Sjögren's syndrome: autoimmune epithelitis.Changes in the Submandibular Salivary Gland Epithelial Cell Subpopulations During Progression of Sjögren's Syndrome-Like Disease in the NOD/ShiLtJ Mouse Model.Comparative Proteomics of Mouse Tears and Saliva: Evidence from Large Protein Families for Functional Adaptation.Smad4 in T cells plays a protective role in the development of autoimmune Sjögren's syndrome in the nonobese diabetic mouse.A review of the toxicology and pathology of the gastrointestinal tract.The value of animal models to study immunopathology of primary human Sjögren's syndrome symptoms.Prdm1 Regulates Thymic Epithelial Function To Prevent Autoimmunity.Innate immunity in Sjögren's syndrome.Interferon-γ treatment in vitro elicits some of the changes in cathepsin S and antigen presentation characteristic of lacrimal glands and corneas from the NOD mouse model of Sjögren's Syndrome.Effects of subconjunctival administration of anti-high mobility group box 1 on dry eye in a mouse model of Sjӧgren's syndrome.Chitinase expression in parotid glands of non-obese diabetic mice.SATB1 Conditional Knockout Results in Sjögren's Syndrome in Mice.A new dry eye mouse model produced by exorbital and intraorbital lacrimal gland excision.Autoantibodies in Sjögren's Syndrome.Anti-IL-7 receptor-α treatment ameliorates newly established Sjögren's-like exocrinopathy in non-obese diabetic mice.MyD88 signaling causes autoimmune sialadenitis through formation of high endothelial venules and upregulation of LTβ receptor-mediated signalingThe role of RORα in salivary gland lesions in patients with primary Sjögren's syndrome
P2860
Q28513579-34F0073B-0E91-417E-A0A1-41CBBAC3CDCCQ33605317-1A70948F-F5C7-43D3-B877-FB18044F5B7BQ33670454-5C70B114-9F89-42BE-8D9E-399D48E1D2B8Q33688996-A1D9D0C7-79D8-41FE-A63D-B10867C8047EQ34457345-B69D15EF-B3AA-4F83-8336-2B5C6131B23BQ34473302-99192700-7312-43B3-9E8E-7F634295410AQ34629461-D8E473A7-A8FD-4D6A-BA1B-918A3F8ACC4CQ35008077-43175152-3635-4A4A-B6A2-AE969AB835C7Q35426932-AEC29DA1-C6AA-4289-837E-B03F6FBF9682Q35587450-786108AC-2A50-4BAF-B990-D32F230D5088Q35688387-A9674498-85E8-4F39-9C3E-3B78E5B9E5D6Q35907701-94517840-87AF-4738-BBD0-5DCCCC221390Q36151756-DFAB78CE-BA3B-494B-B50F-9862FF19258FQ36506691-7CA3D5A6-D714-400C-A843-457A2BECFBCEQ36599248-3DC6A3E2-0722-4E28-8C23-88E4436C0F25Q36954880-D1587A05-465C-4CD1-9497-B0E36B72F277Q37566464-5B51ACBE-D877-4AC2-A1B6-07F2CC757D2FQ37696996-0C0C59E0-3C90-4F48-A689-EED198D49D34Q38132657-6A2122DA-C0F4-48F1-83F6-C64302CFCEF5Q38186111-AC56FCBD-E5C6-4AB1-BF32-5EDC21448DE3Q38682042-FD6EB00A-3CD0-404B-B627-F00D2F3EF0CCQ39232871-82397DC3-ECE1-4069-B674-937300B4C410Q41140614-EBFB4CCE-6AFF-467E-A26E-DAECD8970965Q41512074-690373FC-BFE7-47AC-BE93-0B516C1C9B9CQ42501693-FC0F947E-959C-4944-A5B3-E6508C5155D5Q45980606-8A6717A9-B748-4082-8663-5FBB9B229048Q48171815-23228DB8-7D72-4274-BAD9-7B8D0FBFD6CAQ50926832-04AD8DB5-A77D-4BF0-8302-E9F2D589746FQ52572230-C96EDC2A-A75A-4393-B17B-5415949218D9Q58700279-D72CCD34-ABE1-4E58-800D-B19DFE402D2DQ58761748-57AD4414-1A3D-4CFB-8845-46FBF9CD360D
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Current concepts: mouse models of Sjögren's syndrome.
@ast
Current concepts: mouse models of Sjögren's syndrome.
@en
Current concepts: mouse models of Sjögren's syndrome.
@nl
type
label
Current concepts: mouse models of Sjögren's syndrome.
@ast
Current concepts: mouse models of Sjögren's syndrome.
@en
Current concepts: mouse models of Sjögren's syndrome.
@nl
prefLabel
Current concepts: mouse models of Sjögren's syndrome.
@ast
Current concepts: mouse models of Sjögren's syndrome.
@en
Current concepts: mouse models of Sjögren's syndrome.
@nl
P2093
P2860
P356
P1476
Current concepts: mouse models of Sjögren's syndrome.
@en
P2093
Byung Ha Lee
Cuong Q Nguyen
Tegan N Lavoie
P2860
P304
P356
10.1155/2011/549107
P577
2010-12-30T00:00:00Z